SBIR/STTR Research Award
DEVELOPMENT AND TESTING OF VIRTUAL REALITY ENHANCED DIALECTIC BEHAVIOR THERAPY DBT FOR ADOLESCENTS WITH DUAL DIAGNOSIS
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AppliedVR, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- N1ZHM72HE9Q7
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
For Phase I of the proposed project we will conduct initial development of a virtual reality enhanced DBT treatment for substance abuse disorders in adolescents with dual diagnoses addiction to any substance or polysubstance use disorder and comorbid mental disorders We will work with treatment professionals to develop appropriate VR content engage stakeholders on the practical implications of using VR for treatment insurance billing data security HIPAA privacy etc determine detailed task analysis and identify potential risks through player usability testing and collect initial qualitative data on patient and clinician reactions to the VR content
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Virtual Reality as an Opioid Sparing Treatment for Chronic Pain
- Virtual Reality as a Opioid Sparing Intervention for Acute Postoperative Pain Management
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
3 SBIR/STTR records share this UEI (2017–2019). Reported award amounts total $3,122,294. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services